UCB Award highlights excellence in neuroscience
Posted by
Henrik Klitgaard, Patient Value Unit - New Medicines
19-May-2017
Two top Belgium-based scientists have won the UCB Award – a €100,000 prize, developed under the aegis of the Queen Elisabeth Medical Foundation for Neuroscientific Research in Belgium.
Professor Pierre Vanderhaeghen at the Université Libre de Bruxelles (ULB) and Professor Fadel Tissir of the Université Catholique de Louvain (UCL) will use the prize fund to support their ongoing neuroscientific research projects.
Professor Vanderhaeghen's project is entitled ‘How to make cortical neurons: mechanisms, evolution and diseases’, while Professor Tissir is working on the role of the planar cell polarity genes in shaping the nervous system.
The UCB Award 2017 was presented to them by HRH Princess Astrid, Honorary President of the Queen Elisabeth Medical Foundation, in the presence of the Foundation's Board of Directors.
The prize demonstrates UCB’s continued support for cutting-edge university research in Belgium. The winners are scientists with global reputations whose neuroscientific work is fully integrated with UCB’s strategic approach to neurology.
In the domain of neurology, researchers from UCB focus particularly on the identification of new treatment opportunities for patients suffering from epilepsy and Parkinson's disease. Expanding scientific knowledge in this field improves our capacity to bring life-changing medicines to patients with serious neurological conditions.
UCB supports both fundamental and applied research in neurology and in immunology, and has strong collaborations with the academic sector. Our solid partnerships with Belgian universities helps to strengthen our own research activities at our Centre of Excellence in Braine l'Alleud.
By supporting Belgium-based researchers, we ensure that our own teams operate in an ecosystem defined by scientific excellence.
Professor Pierre Vanderhaeghen at the Université Libre de Bruxelles (ULB) and Professor Fadel Tissir of the Université Catholique de Louvain (UCL) will use the prize fund to support their ongoing neuroscientific research projects.
Professor Vanderhaeghen's project is entitled ‘How to make cortical neurons: mechanisms, evolution and diseases’, while Professor Tissir is working on the role of the planar cell polarity genes in shaping the nervous system.
The UCB Award 2017 was presented to them by HRH Princess Astrid, Honorary President of the Queen Elisabeth Medical Foundation, in the presence of the Foundation's Board of Directors.
The prize demonstrates UCB’s continued support for cutting-edge university research in Belgium. The winners are scientists with global reputations whose neuroscientific work is fully integrated with UCB’s strategic approach to neurology.
In the domain of neurology, researchers from UCB focus particularly on the identification of new treatment opportunities for patients suffering from epilepsy and Parkinson's disease. Expanding scientific knowledge in this field improves our capacity to bring life-changing medicines to patients with serious neurological conditions.
UCB supports both fundamental and applied research in neurology and in immunology, and has strong collaborations with the academic sector. Our solid partnerships with Belgian universities helps to strengthen our own research activities at our Centre of Excellence in Braine l'Alleud.
By supporting Belgium-based researchers, we ensure that our own teams operate in an ecosystem defined by scientific excellence.
Leave a Comment
Another example of UCB's commitment in the field of neuroscience
gryt
testComment
Test